Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

275 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Quadruple induction therapy including antithymocyte globulin or interleukin-2 receptor antibody or FK 506-based induction therapy after liver transplantation.
Lohmann R, Langrehr JM, Klupp J, Neumann U, Guckelberger O, Müller AR, Nüssler NC, Jonas S, Lang M, Settmacher U, Bechstein WO, Neuhaus PJ. Lohmann R, et al. Transplant Proc. 1999 Feb-Mar;31(1-2):380. doi: 10.1016/s0041-1345(98)01670-4. Transplant Proc. 1999. PMID: 10083151 No abstract available.
Interleukin-2 receptor antibody versus antithymocyte globulin as part of quadruple induction therapy after orthotopic liver transplantation: a randomized study.
Langrehr JM, Guckelberger O, Nüssler N, Radtke A, Lemmens HP, Jonas S, Lohmann R, Tullius S, Steinmüller T, Raakow R, Neumann U, Knoop M, Bechstein WO, Neuhaus P. Langrehr JM, et al. Among authors: lohmann r. Transplant Proc. 1996 Dec;28(6):3204. Transplant Proc. 1996. PMID: 8962241 Clinical Trial. No abstract available.
A prospective randomized trial comparing interleukin-2 receptor antibody versus antithymocyte globulin as part of a quadruple immunosuppressive induction therapy following orthotopic liver transplantation.
Langrehr JM, Nüssler NC, Neumann U, Guckelberger O, Lohmann R, Radtke A, Jonas S, Klupp J, Steinmüller T, Lobeck H, Meuer S, Schlag H, Lemmens HP, Knoop M, Keck H, Bechstein WO, Neuhaus P. Langrehr JM, et al. Among authors: lohmann r. Transplantation. 1997 Jun 27;63(12):1772-81. doi: 10.1097/00007890-199706270-00012. Transplantation. 1997. PMID: 9210503 Clinical Trial.
275 results